Loading stock data…
ADMA Biologics (ADMA)
$8.43-0.32 (-3.71%)
Market OpenUpdated 3:09 PM EDT
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
ADMA Biologics, Inc. in the Healthcare sector is trading at $8.42 with a market capitalization of $2.0B. Wall Street consensus targets $17.60 (5 analysts), implying a +108.9% move over the next 12 months. The stock is currently near its 52-week low of $7.21, remaining 40.2% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +108.9% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $114.49M↓ | $139.16M↑ | $134.22M↑ | $121.98M↑ | $114.80M |
| Gross Profit | $80.75M↓ | $88.82M↑ | $75.63M↑ | $67.23M↑ | $61.10M |
| Operating Income | $50.29M↓ | $62.75M↑ | $51.01M↑ | $42.80M↑ | $34.88M |
| Net Income | $45.33M↓ | $49.38M↑ | $36.43M↑ | $34.22M↑ | $26.90M |
Peer Comparison
JNJUNHPFE
Fundamentals
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.98B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Elite ROE. Management converts capital into profit efficiently.
42.36%
Volume
Today's trading volume
2.30M
Recent News
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
Adma Biologics (ADMA) concluded the recent trading session at $8.69, signifying a +1.4% move from its prior day's close.
3 Biotech Firms With Major Potential Catalysts in the Coming Months
The pharmaceutical industry is known for big risks and big rewards among investors; those willing to take on the risk may want to watch these firms.
ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation Allegations
With an upside potential of 121.45%, ADMA Biologics, Inc. (NASDAQ:ADMA) ranks among the stocks under $20 that will explode. The company is navigating a sharp divide between bullish analyst sentiment and mounting legal scrutiny tied to allegations from earlier this year. On June 10, 2026, Raymond James analyst Ryan Deschner resumed coverage of ADMA Biologics, […]
Adma Biologics (ADMA) Dips More Than Broader Market: What You Should Know
The latest trading day saw Adma Biologics (ADMA) settling at $8.42, representing a -1.86% change from its previous close.
Adma Biologics (ADMA) Stock Dips While Market Gains: Key Facts
Adma Biologics (ADMA) closed the most recent trading day at $8.33, moving 1.83% from the previous trading session.